Abstract:Head and neck squamous cell carcinoma (HNSCC) is a molecularly and spatially heterogeneous disease frequently characterized by impairment of immunosurveillance mechanisms. Despite recent success with immunotherapy treatment, disease progression still occurs quickly after treatment in the majority of cases, suggesting the need to improve patient selection strategies. In the quest for biomarkers that may help inform response to checkpoint blockade, we characterized the tumor microenvironment (TME) of 162 HNSCC primary tumors of diverse etiologic and spatial origin, through gene expression and IHC profiling of relevant immune proteins, T-cell receptor (TCR) repertoire analysis, and whole-exome sequencing. We identified five HNSCC TME categories based on immune/stromal composition: (i) cytotoxic, (ii) plasma cell rich, (iii) dendritic cell rich, (iv) macrophage rich, and (v) immune-excluded. Remarkably, the cytotoxic and plasma cell rich subgroups exhibited a phenotype similar to tertiary lymphoid structures (TLS), which have been previously linked to immunotherapy response. We also found an increased richness of the TCR repertoire in these two subgroups and in never smokers. Mutational patterns evidencing APOBEC activity were enriched in the plasma cell high subgroup. Furthermore, specific signal propagation patterns within the Ras/ERK and PI3K/AKT pathways associated with distinct immune phenotypes. While traditionally CD8/CD3 T-cell infiltration and immune checkpoint expression (e.g., PD-L1) have been used in the patient selection process for checkpoint blockade treatment, we suggest that additional biomarkers, such as TCR productive clonality, smoking history, and TLS index, may have the ability to pull out potential responders to benefit from immunotherapeutic agents. Significance: Here we present our findings on the genomic and immune landscape of primary disease in a cohort of 162 patients with HNSCC, benefitting from detailed molecular and clinical characterization. By employing whole-exome sequencing and gene expression analysis of relevant immune markers, TCR profiling, and staining of relevant proteins involved in immune response, we highlight how distinct etiologies, cell intrinsic, and environmental factors combine to shape the landscape of HNSCC primary disease.

Heterogeneous characterization of neutrophilic cells in head and neck cancers

Neutrophils in cancer: heterogeneous and multifaceted

Brief review on the roles of neutrophils in cancer development

The Evolution and Heterogeneity of Neutrophils in Cancers: Origins, Subsets, Functions, Orchestrations and Clinical Applications

Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies

The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer

Multifaceted Roles of Neutrophils in Tumor Microenvironment

Neutrophils in Cancer immunotherapy: friends or foes?

Neutrophils in cancer: dual roles through intercellular interactions

Neutrophil: A New Player in Metastatic Cancers

[Neutrophils in the tumor microenvironment-foes or friends?]

Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy

Naive primary neutrophils play a dual role in the tumor microenvironment

Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC

Single‐cell transcriptome analysis reveals heterogeneity of neutrophils in non‐small cell lung cancer

Heterogeneity of myeloid cells in common cancers: Single cell insights and targeting strategies

Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma

Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal

Neutrophils in HNSCC Can Be Associated with Both a Worse or Favorable Prognosis

Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice

Unraveling the Multifaceted Role in the Tumor Microenvironment